module 14 gonadal hormone inhibitors Flashcards
synthesis of progestins, androgens, and estrogens
cholesterol is the main precursor
- all are lipophilic
progestines
17a hydroxyprogesterone
progesterone
-> converted to testosterone which is converted to estradiol
Androgens
testosterone -> converted to estradiol Dehydroepiandrosterone DHEA -> converted to Androstenedione Androstenedione -> converted to estrone
estrogens
estradiol
-> converted to estriol
estrone
-> converted to estriol
5a-reductase inhibitors meds
finasteride
dutasteride
5a-reductase inhibitors MOA
competitive, selective inhibitors
inhibits testosterone -> dihydrotestosterone conversion
dihydrotestosterone
binds to androgen Rc with 10-fold higher affinity than testosterone
aromatase inhibitors
competitive inhibitors - anastrazole - letrozole bind covalently: - exemestane - formestane
aromatase inhibitors MOA
inhibit androgen to estrogen conversion
- testosterone -> estradiol
- androstenedione -> estrone
aromatase inhibitors use
breast canter that is hormone responsive (ER+)
aromatase inhibitor AE
suppression of estrogen
- dec. bone density
- inc. risk osteoporosis/fx
selective estrogen Rc modulators (SERM) meds
tamoxifen
raloxifene
clomiphene
tamoxifen MOA
tissue specific agonist/antagonist effects
- inhibits growth of estrogen dependent breast tumors
- stimulatory in bones
Tamoxifen AE
stimulates endometrial cancer
raloxifene MOA
stimulates bone
- delay or prevent osteoporosis
inhibits breast and endometrium
clomiphene MOA
induces ovulation
- Estrogen Rc antagonist in hypothalamus. anterior pituitary
- > inc. GnRH
estrogen Rc antagonist med
fulvestrant
fulvestrant MOA
pure antagonist
competitively inhibits ER in breast cancer cells
fulvestrant use
breast cancer that is hormonally responsive
slows tumor growth
androgen Rc antagonist meds
flutamide
bicalcutamide
spironolactone
androgen Rc antagonist MOA
competitively inhibits binding of androgen to androgen Rc
flutamide and bicalutamide use
prostate cancer
BPH
spironolactone use
hirsutism
progesterone Rc antagonist med
mifepristone (RU-486)
mifepristone MOA
competitive inhibition of progesterone action
mifepristone use
1st trimester termination of pregnancy
GnRH agonists
leuprolide
goserelin
nafarelin
GnRH Rc antagonist
cetrorelix
ganirelix